The synthetic route of 42923-77-3 has been constantly updated, and we look forward to future research findings.
42923-77-3, 6-Methoxy-1,2,3,4-tetrahydroisoquinoline is a tetrahydroisoquinoline compound, ?involved in a variety of chemical synthesis. Rlated chemical reaction is continuously updated
General procedure: A mixture of 4-(aminosulfonyl)benzoic acid (7) (2 mmol,402 mg), N,N,N0,N0-tetramethyl-O-(1H-benzotriazol-1-yl)uraniumhexafluorophosphate (HBTU) (2 mmol, 758 mg) in dimethylformamide(2 mL) was stirred at room temperature for 1 h. Then, a solution of the appropriate 1,2,3,4-tetrahydroisoquinoline(6a,c,e) or 1,2,3,4-tetrahydroquinoline (8c,e) (2 mmol) in TEA(2 mmol, 278 mL) was added dropwise. The reaction mixture wasleft overnight and then quenched with water (10 mL) and extractedwith EtOAc (3 5 mL). The organic phase was dried with Na2SO4and the solvent was removed in vacuo. The residue was purified byflash chromatography (DCM/MeOH 96:4), crystallized by treatmentwith diethyl ether and ethanol giving the desired final compounds4a,c,e and 5cee as white crystals. As starting reagent the benzamide3a was re-synthesized following a previously reported procedureand the spectral datawas in accordance with literature [37].The methoxy derivatives 3a, 4a,c and 5c (1 mmol) were dissolved inmethylene chloride (DCM) (5 mL), treated with BBr3 (1 M in DCM)(6 mmol, 6 mL) under nitrogen atmosphere and stirred overnight.After completion of the reaction, MeOH (7 mL) was carefully addedat 0 C and the solvents removed under reduced pressure. Theresidue was dissolved in EtOAc (10 mL) and washed with H2O(10mL 3). The organic layerwas dried (Na2SO4) and concentratedin vacuo. The crude products were crystallized from diethyl ether togive the desired corresponding hydroxy-derivatives 3b, 4b,d and5d. 4.1.1.3 4-[(6-Methoxy-3,4-dihydroisoquinolin-2(1H)-yl)carbonyl]benzenesulfonamide (4c) Yield 74%; mp 181-182 C; Rf = 0.46; 1H NMR (DMSO-d6): the compound exists as a pair of rotamers at room temperature. delta 2.79 (mc, 2H, major rotamer, CH2), 2.85 (mc, 2H, minor rotamer, CH2), 3.46 (mc, 2H, major rotamer, CH2), 3.70 (s, 3H, OCH3), 3.81 (mc, 2H, minor rotamer, CH2), 4.42 (mc, 2H, minor rotamer, CH2), 4.69 (mc, 2H, major rotamer, CH2), 6.74-7.18 (m, 3H, ArH), 7.47 (bs, 2H, NH2), 7.63 (d, J = 7.7, 2H, ArH), 7.87 (d, J = 8.2, 2H, ArH); GC-MS (EI) m/z (%): 346 (M+, 0), 222 (4.3), 194 (0.5), 177 (35), 176 (18), 164 (0.5), 150 (15), 149 (100), 121 (6.2), 105 (7.8); Anal. C17H18N2O4S., 42923-77-3
The synthetic route of 42923-77-3 has been constantly updated, and we look forward to future research findings.
Reference£º
Article; Buemi, Maria Rosa; De Luca, Laura; Ferro, Stefania; Bruno, Elvira; Ceruso, Mariangela; Supuran, Claudiu T.; Pospi?ilova, Klara; Brynda, Ji?i; ?eza?ova, Pavlina; Gitto, Rosaria; European Journal of Medicinal Chemistry; vol. 102; (2015); p. 223 – 232;,
Tetrahydroisoquinoline – Wikipedia
1,2,3,4-Tetrahydroisoquinoline | C9H11N – PubChem